Cancer Cell Resistance Against the Clinically Investigated Thiosemicarbazone COTI-2 Is Based on Formation of Intracellular Copper Complex Glutathione Adducts and ABCC1-Mediated Efflux

Bormio Nunes Julia H. and Hager Sonja and Mathuber Marlene and Pósa Vivien and Roller Alexander and Enyedy Éva Anna and Stefanelli Alessia and Berger Walter and Keppler Bernhard K. and Heffeter Petra and Kowol Christian R.: Cancer Cell Resistance Against the Clinically Investigated Thiosemicarbazone COTI-2 Is Based on Formation of Intracellular Copper Complex Glutathione Adducts and ABCC1-Mediated Efflux.
JOURNAL OF MEDICINAL CHEMISTRY, 63. pp. 13719-13732. ISSN 0022-2623 (2020)

[thumbnail of 31661639.pdf]
Preview
Text
31661639.pdf - Published Version

Download (5MB) | Preview
Item Type: Journal Article
Journal or Publication Title: JOURNAL OF MEDICINAL CHEMISTRY
Date: 2020
Volume: 63
Page Range: pp. 13719-13732
ISSN: 0022-2623
Faculty/Unit: Faculty of Science and Informatics
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 31661639
DOI azonosító: https://doi.org/10.1021/acs.jmedchem.0c01277
Date Deposited: 2020. Dec. 14. 12:24
Last Modified: 2020. Dec. 14. 12:24
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/20066
Web of Science® Times Cited: 13 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year